Organigram Holdings Inc. Depreciation & Amortization

Depreciation & Amortization of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Depreciation & Amortization growth rates and interactive chart.


Highlights and Quick Summary

  • Depreciation & Amortization for the quarter ending February 28, 2022 was $4.75 Million (a 0.22% increase compared to previous quarter)
  • Year-over-year quarterly Depreciation & Amortization increased by 3.44%
  • Annual Depreciation & Amortization for 2021 was $24.6 Million (a 79.67% increase from previous year)
  • Annual Depreciation & Amortization for 2020 was $13.7 Million (a 104.81% increase from previous year)
  • Annual Depreciation & Amortization for 2019 was $6.69 Million (a 146.63% increase from previous year)
  • Twelve month Depreciation & Amortization ending February 28, 2022 was $26 Million (a 2.44% increase compared to previous quarter)
  • Twelve month trailing Depreciation & Amortization increased by 52.63% year-over-year
Trailing Depreciation & Amortization for the last four month:
28 Feb '22 30 Nov '21 31 Aug '21 31 May '21
$26 Million $25.4 Million $24.6 Million $17 Million
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Depreciation & Amortization of Organigram Holdings Inc.

Most recent Depreciation & Amortizationof OGI including historical data for past 10 years.

Interactive Chart of Depreciation & Amortization of Organigram Holdings Inc.

Organigram Holdings Inc. Depreciation & Amortization for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $4.75
2021 $4.74 $11.9 $4.59 $4.13 $24.63
2020 $4.0 $4.3 $3.23 $3.28 $13.71
2019 $2.54 $2.47 $1.62 $1.33 $6.69
2018 $1.29 $7.38 $2.71
2017 $1.23
2016 $0.6

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic